Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT05260866 |
| Other study ID # |
ANR-21-COVR-0010-01 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
July 1, 2021 |
| Est. completion date |
June 30, 2022 |
Study information
| Verified date |
February 2022 |
| Source |
Assistance Publique - Hôpitaux de Paris |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
Mental health consequences of the COVID-19 pandemic may be vast and may potentially overwhelm
the mental health system in a long-lasting manner. Evaluating the effects of the COVID-19
pandemic on mental health in vulnerable groups such as children and adolescents has become an
immediate priority. The aim of this study is to evaluate the impact of COVID-19 pandemic on
use of mental health resources namely 1) prescriptions of psychotropic medications and 2)
mental health-related outpatient visits, hospitalizations and emergency department visits in
children and adolescents in France. Secondary aim is to evaluate the impact of the pandemic
on episodes of fatal and non-fatal self-harm episodes in the same population. This will be a
population-based cohort study using data from healthcare claims, administrative medical and
outpatient drug dispensation databases in France between January 1, 2016 and June 1, 2021.
Findings will inform on the risk of upcoming outbreaks of mental disorders that can result in
significant morbidity and mortality and guide timely targeted actions to improve mental
health outcomes and wellbeing in the youngest.
Description:
Mental health consequences of the COVID-19 pandemic may be vast and may potentially overwhelm
the mental health system in a long-lasting manner. Evaluating the effects of the COVID-19
pandemic on mental health in vulnerable groups such as children and adolescents has become an
immediate priority. The aim of this study is to evaluate the impact of COVID-19 pandemic on
use of mental health resources namely 1) prescriptions of psychotropic medications and 2)
mental health-related outpatient visits, hospitalizations and emergency department visits in
children and adolescents in France. Secondary aim is to evaluate the impact of the pandemic
on episodes of fatal and non-fatal self-harm episodes in the same population. This will be a
population-based cohort study using data from healthcare claims, administrative medical and
outpatient drug dispensation databases in France between January 1, 2016 and June 1, 2021.
Findings will inform on the risk of upcoming outbreaks of mental disorders that can result in
significant morbidity and mortality and guide timely targeted actions to improve mental
health outcomes and wellbeing in the youngest.
